Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

MicroTransponder Inc
Profile last edited on: 12/3/2020      CAGE: 4PJK4      UEI: N3WDS9WM91M4

Business Identifier: Neurostimulation devices to treat neurological diseases
Year Founded
2007
First Award
2008
Latest Award
2016
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

2802 Flintrock Trace
Austin, TX 75230
   (972) 227-1160
   info@microtransponder.com
   www.microtransponder.com
Location: Single
Congr. District: 32
County: Dallas

Public Profile

Spun out of the University of Texas at Dallas, MicroTransponder Inc. (MTI) is a medical device company having developed therapies to treat several neurological conditions to include Tinnitus and Stroke. Based on decades of neuroscience research, the firm operations are anchored in the Paired Vagus Nerve Stimulation System (Paired VNS™ System). The Paired VNS™ System has been developed to treat two separate neurological conditions. The first is the Serenity® System for the treatment of chronic tinnitus. The second is the Vivistim® System for treatment of post-stroke upper limb mobility issues.

Extent of SBIR involvement

User Avatar
Phase I Awards
7
Phase II Awards
2
Conversion Rate
28.57%
Phase I Dollars
$1,184,649
Phase II Dollars
$7,333,462
Total Awarded
$8,518,111

Synopsis: Awardee Business Condition

Employee Range
15-19
Revenue Range
1.5M-2M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
10-14

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2016 1 NIH $224,257
Project Title: An Adjunct to Prolonged Exposure Therapy for Treating Refractory Ptsd Patients
2013 2 NIH $5,044,621
Project Title: Targeted Neural Plasticity for the Treatment of Tinnitus
2013 1 NIH $225,043
Project Title: A Novel Adjunct To Physical Training To Improve Motor Recovery Following Stroke
2012 2 NIH $2,511,622
Project Title: Wireless Neurostimulation for the Relief of Chronic Neuropathic and Inflammatory
2010 1 NIH $286,398
Project Title: Enhancing Fear Extinction Using Vagus Nerve Stimulation

Key People / Management

  Jordan Curnes -- Founder, President and COO

  Frank McEachern -- Chief Executive Officer; Chief Financial Officer; General Counsel

  Jean-Philippe (Jp) Allar -- Sr. VP of Sales and Marketing, International

  Scott Armstrong

  Larry Cauller -- Co-Founder

  Navzer Engineer -- Chief Scientific Officer

  Ravi Jain

  Ravi Jain -- Director of Engineering

  Will Rosellini -- Chairman of the Board

  Brent Tarver

  Richard L Weiner

Company News

Dec 31 2015
MicroTransponder developing neurostimulation technology to allow tinnitus and stroke victims to re-train their brains
Aug 28 2013
MicroTransponder Announces $3M in Funding, the First Patient Implant in a Stroke Clinical Trial, and Key Patent Issuance